Cerebrovascular and Neurocognitive Research Group (CNRG)
Welcome to the Cerebrovascular and Neurocognitive Research Group (CNRG)
A multidisciplinary group of clinical and bench researchers has been formed at the University of Rochester Medical Center (URMC) to study cerebrovascular disease. The Cerebrovascular and Neurocognitive Research Group (CNRG), which consists of faculty from Neurology, Neurosurgery, Electrical and Computer Engineering, Microbiology and Immunology, and Vascular Biology will leverage advanced brain imaging technologies to investigate a number of diseases, including stroke, cerebral small vessel disease (CSVD), and vascular dementia.
Significant scientific advances in cerebrovascular and related neurocognitive disorders require an infrastructure that facilitates collaborations among clinicians, clinical and basic scientists. CNRG will become a catalyst for innovative research in cerebrovascular and related neurocognitive disorders, providing the link between basic research and clinical trials.
These efforts are being supported in part by a new $2.7 million grant from the National Institute of Mental Health, to study how chronic inflammation drives cerebrovascular disease and disrupts the structure and connections between different parts of the brain.
Research Areas
- Acute Stroke
- Stroke Prevention
- Pre-clinical stroke modeling
- Drug discovery
- Post-stroke recovery
- Chronic cerebrovascular disease
- Vasculitides
- Vascular dementia
- Neurologic Emergencies (NeuroICU)
Publications
- Increased brain volume in idiopathic intracranial hypertension: Association with intracranial pressure and papilledema severity.; Journal of the neurological sciences; Vol 473, pp. 123501. 2025 Apr 12.
- Fast fluid-attenuated T2 mapping via multiple overlapping-echo detachment acquisition enhances preoperative histological classification of meningiomas.; NeuroImage; Vol 311, pp. 121186. 2025 Apr 02.
- Mobile Stroke Units Address Socioeconomic Disparities in Care.; Neurosurgery. 2025 Mar 12.
- MR perfusion characteristics of pseudoprogression in brain tumors treated with immunotherapy - a comparative study with chemo-radiation induced pseudoprogression and radiation necrosis.; Journal of neuro-oncology. 2024 Dec 17.
Contact Us
Cerebrovascular and Neurocognitive Research Group (CNRG)
601 Elmwood Ave
Rochester, NY 14642
Giovanni Schifitto, M.D.
(Neuroimaging Core)
(585) 276-1870
Marc Halterman, M.D., Ph.D.
(Stroke Biomarker Core)
(585) 273-3030
Curtis Benesch, M.D., M.P.H.
(Human Studies Core)
(585) 275-2530